These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27346669)

  • 21. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An overview of pluripotent stem cell lines].
    Kieffer E; Kuntz S; Viville S
    Med Sci (Paris); 2010 Oct; 26(10):848-54. PubMed ID: 20929676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Status of human germ cell differentiation from pluripotent stem cells.
    Pera RA
    Reprod Fertil Dev; 2013; 25(2):396-404. PubMed ID: 23445816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combined chemical and genetic approach for the generation of induced pluripotent stem cells.
    Shi Y; Do JT; Desponts C; Hahm HS; Schöler HR; Ding S
    Cell Stem Cell; 2008 Jun; 2(6):525-8. PubMed ID: 18522845
    [No Abstract]   [Full Text] [Related]  

  • 25. Personalized Medicine: Cell and Gene Therapy Based on Patient-Specific iPSC-Derived Retinal Pigment Epithelium Cells.
    Li Y; Chan L; Nguyen HV; Tsang SH
    Adv Exp Med Biol; 2016; 854():549-55. PubMed ID: 26427458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects.
    Higuchi A; Ku NJ; Tseng YC; Pan CH; Li HF; Kumar SS; Ling QD; Chang Y; Alarfaj AA; Munusamy MA; Benelli G; Murugan K
    Lab Invest; 2017 Oct; 97(10):1167-1179. PubMed ID: 28869589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of induced pluripotent stem cells into functional oligodendrocytes.
    Czepiel M; Balasubramaniyan V; Schaafsma W; Stancic M; Mikkers H; Huisman C; Boddeke E; Copray S
    Glia; 2011 Jun; 59(6):882-92. PubMed ID: 21438010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical potentials of human pluripotent stem cells.
    Mora C; Serzanti M; Consiglio A; Memo M; Dell'Era P
    Cell Biol Toxicol; 2017 Aug; 33(4):351-360. PubMed ID: 28176010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced pluripotent stem cells: it's like déjà vu all over again.
    Schenke-Layland K; MacLellan WR
    Circulation; 2009 Oct; 120(15):1462-4. PubMed ID: 19786628
    [No Abstract]   [Full Text] [Related]  

  • 30. Regenerating Perfection.
    Clegg DO
    J Ocul Pharmacol Ther; 2016 Jun; 32(5):237. PubMed ID: 27214692
    [No Abstract]   [Full Text] [Related]  

  • 31. Turning everything into brain?
    Kundu B; Kuo JS; Dempsey RJ
    Neurosurgery; 2010 Aug; 67(2):N16-7. PubMed ID: 20644402
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bipolar disorder: advances in the prediction of lithium response and development of new therapies using induced pluripotent stem cells].
    Santos R; Charnay P
    Med Sci (Paris); 2017 Dec; 33(12):1048-1050. PubMed ID: 29261491
    [No Abstract]   [Full Text] [Related]  

  • 33. Modelling multiple sclerosis using induced pluripotent stem cells.
    Martínez-Larrosa J; Matute-Blanch C; Montalban X; Comabella M
    J Neuroimmunol; 2020 Dec; 349():577425. PubMed ID: 33130461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies.
    Scheiner ZS; Talib S; Feigal EG
    J Biol Chem; 2014 Feb; 289(8):4571-7. PubMed ID: 24362036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies.
    Selvaraj S; Kyba M; Perlingeiro RCR
    Trends Mol Med; 2019 Sep; 25(9):803-816. PubMed ID: 31473142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioengineering: Doing without donors.
    Dolgin E
    Nature; 2017 Sep; 549(7673):S12-S15. PubMed ID: 28953861
    [No Abstract]   [Full Text] [Related]  

  • 37. Developing an automated robotic factory for novel stem cell therapy production.
    Rafiq QA; Twomey K; Kulik M; Leschke C; O'Dea J; Callens S; Gentili C; Barry FP; Murphy M
    Regen Med; 2016 Jun; 11(4):351-4. PubMed ID: 27168080
    [No Abstract]   [Full Text] [Related]  

  • 38. Regenerating the kidney using human pluripotent stem cells and renal progenitors.
    Becherucci F; Mazzinghi B; Allinovi M; Angelotti ML; Romagnani P
    Expert Opin Biol Ther; 2018 Jul; 18(7):795-806. PubMed ID: 29939787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced pluripotent stem cells and promises of neuroregenerative medicine.
    Verma A; Verma N
    Neurol India; 2011; 59(4):555-7. PubMed ID: 21891933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Back to the future: how human induced pluripotent stem cells will transform regenerative medicine.
    Svendsen CN
    Hum Mol Genet; 2013 Oct; 22(R1):R32-8. PubMed ID: 23945396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.